JAMES C MOMTAZEE
CIK 1209181 · Chief Executive Officer · last filed 2026-07-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$16.88M
Companies
8
Total Filings
58
Lifetime Open-Market Net
$1.07M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | Director | 109,810 | $33.84 | $3.72M | $0 | 17 | 2026-07-21 |
| BBIO | Director | 99,070 | $85.55 | $8.48M | $1.16M | 10 | 2026-06-24 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Director | 62,789 | $2.75 | $172.7K | $0 | 6 | 2023-07-06 |
| PRA Health Sciences, Inc. (PRAH) Delisted | Director | 0 | $165.21 | $0 | $0 | 4 | 2021-07-01 |
| Montes Archimedes Acquisition Corp (MAACU) Delisted | Chief Executive Officer | — | $10.17 | — | $0 | 1 | 2020-11-20 |
| ENTELLUS MEDICAL INC (ENTL) Delisted | Director | 0 | — | — | $0 | 2 | 2018-03-01 |
| JAZZ | Director | 17,315 | $256.92 | $4.45M | -$87.6K | 14 | 2013-08-14 |
| AIQ | Director | 4,162 | $57.24 | $238.2K | $0 | 3 | 2007-06-01 |
Recent Filings · Page 2 of 6
58 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-23 | ROIV | Grant (A) | +1,231 | $0 | EDGAR |
| 2024-09-16 | ROIV | Other (J) | −3,056 | -$37.0K | EDGAR |
| 2024-09-12 | ROIV | Grant (A) | +16,406 | $0 | EDGAR |
| 2024-07-25 | ROIV | Grant (A) | +1,555 | $0 | EDGAR |
| 2024-06-25 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2024-04-26 | ROIV | Mixed | +1,197 | -$3.2K | EDGAR |
| 2024-01-23 | ROIV | Grant (A) | +1,570 | $0 | EDGAR |
| 2023-10-18 | ROIV | Mixed | +907 | -$7.1K | EDGAR |
| 2023-10-17 | ROIV | Notice (144) | −687 | -$7.0K | EDGAR |
| 2023-09-20 | ROIV | Other (J) | −6,752 | -$75.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.